Gastric Acid Inhibition for Fat Malabsorption or Gastroesophageal Reflux Disease in Cystic Fibrosis: Longitudinal Effect on Bacterial Colonization and Pulmonary Function

Journal of Pediatrics

Volumn 155, Issue 5, 2009, Pages 629-633

  van der Doef, Hubert P J ^a   Arets, Hubertus G M ^a   Froeling, Steven P ^a   Westers, Paul ^a   Houwen, Roderick H J ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

HISTAMINE H2 RECEPTOR ANTAGONIST; PANCREAS ENZYME; PROTON PUMP INHIBITOR;

ARTICLE; BACTERIAL COLONIZATION; BACTERIAL SURVIVAL; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; CYSTIC FIBROSIS; DISEASE ASSOCIATION; ENZYME THERAPY; FAT MALABSORPTION; FEMALE; FORCED EXPIRATORY VOLUME; GASTROESOPHAGEAL REFLUX; HUMAN; LONGITUDINAL STUDY; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALABSORPTION; MALE; MECONIUM ILEUS; PARAMETER; PEAK EXPIRATORY FLOW; PEDIATRICS; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RETROSPECTIVE STUDY; SCHOOL CHILD; STAPHYLOCOCCUS AUREUS; STOMACH ACID;

ADOLESCENT; CHILD; COHORT STUDIES; COLONY COUNT, MICROBIAL; CYSTIC FIBROSIS; FEMALE; FOLLOW-UP STUDIES; FORCED EXPIRATORY VOLUME; GASTRIC ACID; GASTROESOPHAGEAL REFLUX; HUMANS; INFANT; INFANT, NEWBORN; LONGITUDINAL STUDIES; MALABSORPTION SYNDROMES; MALE; MULTIVARIATE ANALYSIS; ODDS RATIO; PROBABILITY; PROPORTIONAL HAZARDS MODELS; PROTON PUMP INHIBITORS; PSEUDOMONAS AERUGINOSA; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; STAPHYLOCOCCUS AUREUS; TREATMENT OUTCOME; VITAL CAPACITY;

EID: 71749088330     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpeds.2009.06.040     Document Type: Article

References (22)

1. Ng S.M., and Jones A.P. Drug therapies for reducing gastric acidity in people with cystic fibrosis. Cochrane Database Syst Rev (2003) CD003424
2. Walkowiak J., Nousia-Arvanitakis S., Henker J., Stern M., Sinaasappel M., and Dodge J.A. Indirect pancreatic function tests in children. J Pediatr Gastroenterol Nutr 40 (2005) 107-114
3. Messori A., Trippoli S., Vaiani M., Gorini M., and Corrado A. Bleeding and pneumonia in intensive care patients given ranitidine and sucralfate for prevention of stress ulcer: meta-analysis of randomised controlled trials. BMJ 321 (2000) 1103-1106
4. Canani R.B., Cirillo P., Roggero P., Romano C., Malamisura B., Terrin G., et al. Therapy with gastric acidity inhibitors increases the risk of acute gastroenteritis and community-acquired pneumonia in children. Pediatrics 117 (2006) e817-e820
5. Laheij R.J., Sturkenboom M.C., Hassing R.J., Dieleman J., Stricker B.H., and Jansen J.B. Risk of community-acquired pneumonia and use of gastric acid-suppressive drugs. JAMA 292 (2004) 1955-1960
6. Stringer D.A., Sprigg A., Juodis E., Corey M., Daneman A., Levison H.J., et al. The association of cystic fibrosis, gastroesophageal reflux, and reduced pulmonary function. Can Assoc Radiol J 39 (1988) 100-102
7. Gustafsson P.M., Fransson S.G., Kjellman N.I., and Tibbling L. Gastro-oesophageal reflux and severity of pulmonary disease in cystic fibrosis. Scand J Gastroenterol 26 (1991) 449-456
8. Hendriks J.J., Kester A.D., Donckerwolcke R., Forget P.P., and Wouters E.F. Changes in pulmonary hyperinflation and bronchial hyperresponsiveness following treatment with lansoprazole in children with cystic fibrosis. Pediatr Pulmonol 31 (2001) 59-66
9. Rudolph C.D., Mazur L.J., Liptak G.S., Baker R.D., Boyle J.T., Colletti R.B., et al. Guidelines for evaluation and treatment of gastroesophageal reflux in infants and children: recommendations of the North American Society for Pediatric Gastroenterology and Nutrition. J Pediatr Gastroenterol Nutr 32 (2001) S1-S31
10. Zapletal A., Samanek M., and Paul T. Lung function in children and adolescents. Methods, reference values. In: Zapletal A. (Ed). Progress in respiration research (1987), Karger, Basel, Switzerland 114-218
11. Lee T.W., Brownlee K.G., Conway S.P., Denton M., and Littlewood J.M. Evaluation of a new definition for chronic Pseudomonas aeruginosa infection in cystic fibrosis patients. J Cyst Fibros 2 (2003) 29-34
12. Welsh M.J., and Smith A.E. Molecular mechanisms of CFTR chloride channel dysfunction in cystic fibrosis. Cell 73 (1993) 1251-1254
13. Houwen RH, van der Doef HP, Sermet I, Munck A, Hauser B, Walkowiak J, et al. The ESPGHAN Cystic Fibrosis Working Group: defining DIOS and constipation in cystic fibrosis with a multicenter study on the incidence, characteristics and treatment of DIOS. J Pediatr Gastroenterol Nutr. In press, 2009.
14. Edwards L.J. Modern statistical techniques for the analysis of longitudinal data in biomedical research. Pediatr Pulmonol 30 (2000) 330-344
15. Kozlowska W.J., Bush A., Wade A., Aurora P., Carr S.B., Castle R.A., et al. Lung function from infancy to the preschool years after clinical diagnosis of cystic fibrosis. Am J Respir Crit Care Med 178 (2008) 42-49
16. Dorfman R., Sandford A., Taylor C., Huang B., Frangolias D., Wang Y., et al. Complex two-gene modulation of lung disease severity in children with cystic fibrosis. J Clin Invest 118 (2008) 1040-1049
17. Mitsushima H., Oishi K., Nagao T., Ichinose A., Senba M., Iwasaki T., et al. Acid aspiration induces bacterial pneumonia by enhanced bacterial adherence in mice. Microb Pathog 33 (2002) 203-210
18. Ramphal R., and Pyle M. Adherence of mucoid and nonmucoid Pseudomonas aeruginosa to acid-injured tracheal epithelium. Infect Immun 41 (1983) 345-351
19. Heine R.G., Button B.M., Olinsky A., Phelan P.D., and Catto-Smith A.G. Gastro-oesophageal reflux in infants under 6 months with cystic fibrosis. Arch Dis Child 78 (1998) 44-48
20. Cucchiara S., Santamaria F., Andreotti M.R., Minella R., Ercolini P., Oggero V., et al. Mechanisms of gastro-oesophageal reflux in cystic fibrosis. Arch Dis Child 66 (1991) 617-622
21. Escobar H., Perdomo M., Vasconez F., Camarero C., del Olmo M.T., and Suárez L. Intestinal permeability to 51Cr-EDTA and orocecal transit time in cystic fibrosis. J Pediatr Gastroenterol Nutr 14 (1992) 204-207
22. Bali A., Stableforth D.E., and Asquith P. Prolonged small-intestinal transit time in cystic fibrosis. Br Med J (Clin Res Ed) 287 (1983) 1011-1013